Patent ID: 11873332
Assignee: NOVO NORDISK A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 7:
8. A sterile lyophilized dosage form of an antibody formulation in a 20 ml vial, which is used for reconstituting the antibody formulation to a volume of 5.0 mL, consisting essentially of:
(i) an antibody within a range of about 225-275 mg;
(ii) histidine within a range of about 15-19 mg;
(iii) poloxamer 188 (PX188) within a range of about 2-2.5 mg; and;
(iv) sucrose within a range of about 400-490 mg;
wherein the antibody comprises a mature heavy chain comprising the amino acid sequence of SEQ ID NO:82 except the C-terminal lysine may be absent and a mature light chain comprising the amino acid sequence of SEQ ID NO:86.